| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On May 22, 2007
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 2005E-0248
|
| Patent Term Extension Application for Fosrenol, U.S. Patent No. 5,968,976
|
|
|
|
|
| 2005E-0255
|
| Patent Extension Application for LUNESTA (exzoplclone), U.S. Patent No. 6,444,673
|
|
|
|
|
| 2006D-0480
|
| Guidance for Industry on Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration
|
|
|
|
|
| 2007N-0121
|
| Use of Medication Guides to Distribute Drug Risk Information to Patients; Public Hearing
|
|
|
|
|
| 2007P-0209
|
| Not to grant final ANDA approval for any generic versions of Toprol-XL, metoprolol succinate extendend-release tablets (metoprolol) 50, mg
|
|
|
|
|
| 2007P-0210
|
| Reclassification Petition for Human Papillomavirus (HPV) DNA Nested Polymerase Chain Reaction (PCR) Detection under Section 513(f), 21 CFR 860 Subpart C
|
|
| |
|
| 2005E-0248
|
| Patent Term Extension Application for Fosrenol, U.S. Patent No. 5,968,976
| |
|
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005E-0255
|
| Patent Extension Application for LUNESTA (exzoplclone), U.S. Patent No. 6,444,673
|
|
|
|
|
| WDL 1
|
| FDA/CDER to the U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006D-0480
|
| Guidance for Industry on Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration
|
|
|
|
|
| NEC 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0121
|
| Use of Medication Guides to Distribute Drug Risk Information to Patients; Public Hearing
|
|
|
|
|
| EAPE 215
|
| Jones, Jovonne
|
| Vol #:
|
| 7
|
|
|
|
|
| EAPE 216
|
| Liversidge, Ellen
|
| Vol #:
|
| 7
|
|
|
|
|
| 2007P-0209
|
| Not to grant final ANDA approval for any generic versions of Toprol-XL, metoprolol succinate extendend-release tablets (metoprolol) 50, mg
|
|
|
|
|
| ACK 1
|
| FDA/DDM to Sandoz Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| CP 1
|
| Sandoz Inc.
|
| Vol #:
|
| 1
|
|
| |
|
| 2007P-0210
|
| Reclassification Petition for Human Papillomavirus (HPV) DNA Nested Polymerase Chain Reaction (PCR) Detection under Section 513(f), 21 CFR 860 Subpart C
|
|
|
|
|
| ACK 1
|
| HiFi DNA Tech, LLC
|
| Vol #:
|
| 1
|
|
|
|
|
| CCP 1
|
| HiFi DNA Tech, LLC
|
| Vol #:
|
| 1
|
|
